Home LiteratureArticle Details
PMID: 16142232 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.

Nature genetics ·Vol. 37 ·No. 10 ·2005-10-00 ·Pages 1047-54

Gupta PB, Kuperwasser C, Brunet JP, Ramaswamy S, Kuo WL, Gray JW, Naber SP, Weinberg RA

Abstract

The aggressive clinical behavior of melanoma suggests that the developmental origins of melanocytes in the neural crest might be relevant to their metastatic propensity. Here we show that primary human melanocytes, transformed using a specific set of introduced genes, form melanomas that frequently metastasize to multiple secondary sites, whereas human fibroblasts and epithelial cells transformed using an identical set of genes generate primary tumors that rarely do so. Notably, these melanomas have a metastasis spectrum similar to that observed in humans with melanoma. These observations indicate that part of the metastatic proclivity of melanoma is attributable to lineage-specific factors expressed in melanocytes and not in other cell types analyzed. Analysis of microarray data from human nevi shows that the expression pattern of Slug, a master regulator of neural crest cell specification and migration, correlates with those of other genes that are important for neural crest cell migrations during development. Moreover, Slug is required for the metastasis of the transformed melanoma cells. These findings indicate that melanocyte-specific factors present before neoplastic transformation can have a pivotal role in governing melanoma progression.

MeSH Terms
Animals Cell Adhesion Cell Differentiation Cell Movement/genetics Cell Transformation, Neoplastic/genetics Genes, Neoplasm/genetics Humans Melanocytes/cytology,metabolism,pathology Melanoma/genetics,pathology Mice Neoplasm Metastasis Oligonucleotide Array Sequence Analysis RNA, Small Interfering/genetics Snail Family Transcription Factors Transcription Factors/genetics,metabolism Tumor Cells, Cultured
Chemicals
RNA, Small Interfering SNAI1 protein, human Snai2 protein, mouse Snail Family Transcription Factors Transcription Factors
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gupta Piyush B
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.
Kuperwasser Charlotte
Brunet Jean-Philippe
Ramaswamy Sridhar
Kuo Wen-Lin
Gray Joe W
Naber Stephen P
Weinberg Robert A
References (42)
42 references, click to expand
  1. Benign "metastatic" cellular blue nevus.
    Ann Plast Surg. 1994 Oct;33(4):426-31 PMID: 7810962
  2. A genetically tractable model of human glioma formation.
    Cancer Res. 2001 May 1;61(9):3556-60 PMID: 11325817
  3. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
    Am J Pathol. 2000 Dec;157(6):2151-9 PMID: 11106587
  4. Inhibition of neural crest migration in Xenopus using antisense slug RNA.
    Dev Biol. 1999 Sep 1;213(1):101-15 PMID: 10452849
  5. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.
    Genes Dev. 2001 Jan 1;15(1):50-65 PMID: 11156605
  6. The SLUG zinc-finger protein represses E-cadherin in breast cancer.
    Cancer Res. 2002 Mar 15;62(6):1613-8 PMID: 11912130
  7. Tyrosine kinase receptor indistinguishable from the c-met protein.
    Nature. 1989 May 11;339(6220):155-6 PMID: 2541345
  8. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Cancer Res. 1996 Dec 1;56(23):5475-83 PMID: 8968104
  9. Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel.
    J Clin Gastroenterol. 1987 Oct;9(5):563-7 PMID: 3680909
  10. Shaping of tumor and drug-resistant genomes by instability and selection.
    Oncogene. 2003 Jul 10;22(28):4370-9 PMID: 12853973
  11. The melanoma epidemic: res ipsa loquitur.
    Oncologist. 2003;8(5):459-65 PMID: 14530499
  12. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma.
    Br J Dermatol. 2004 Feb;150(2):179-85 PMID: 14996086
  13. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas.
    Nat Genet. 2001 Dec;29(4):459-64 PMID: 11694878
  14. Expression of CD44H in the cells of neural crest origin in peripheral nervous system.
    Neuroreport. 1996 Jul 29;7(11):1713-6 PMID: 8905649
  15. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14723-8 PMID: 9843956
  16. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
    Nucleic Acids Res. 1990 Jun 25;18(12):3587-96 PMID: 2194165
  17. Benign nevus cells in the capsule of lymph nodes.
    Cancer. 1969 Mar;23(3):747-53 PMID: 5766512
  18. Fully automatic quantification of microarray image data.
    Genome Res. 2002 Feb;12(2):325-32 PMID: 11827952
  19. Detection of specific sequences among DNA fragments separated by gel electrophoresis.
    J Mol Biol. 1975 Nov 5;98(3):503-17 PMID: 1195397
  20. Thin malignant melanomas and recurrence potential.
    Arch Surg. 1987 Oct;122(10):1147-50 PMID: 3662794
  21. Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment.
    Cancer Res. 2000 May 15;60(10):2723-9 PMID: 10825147
  22. Creation of human tumour cells with defined genetic elements.
    Nature. 1999 Jul 29;400(6743):464-8 PMID: 10440377
  23. Immortalization and transformation of primary human airway epithelial cells by gene transfer.
    Oncogene. 2002 Jul 4;21(29):4577-86 PMID: 12085236
  24. The genetics of malignant melanoma: lessons from mouse and man.
    Nat Rev Cancer. 2003 Aug;3(8):559-70 PMID: 12894244
  25. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
    Oncogene. 2001 Dec 6;20(56):8125-35 PMID: 11781826
  26. Murine models of malignant melanoma.
    Mol Med Today. 2000 Oct;6(10):408-10 PMID: 11006531
  27. Neural crest cell migration in the developing embryo.
    Trends Cell Biol. 1993 Nov;3(11):392-7 PMID: 14731657
  28. Examination of steroid-induced changes in LHRH gene transcription using 33P-and 35S-labeled probes specific for intron 2.
    Endocrinology. 1996 Jan;137(1):234-9 PMID: 8536618
  29. Malignant melanomas in the small intestine: a study of 103 patients.
    Am J Gastroenterol. 1996 May;91(5):1001-6 PMID: 8633538
  30. Lentivirus-delivered stable gene silencing by RNAi in primary cells.
    RNA. 2003 Apr;9(4):493-501 PMID: 12649500
  31. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma.
    Proc Natl Acad Sci U S A. 1980 Feb;77(2):1039-43 PMID: 6928659
  32. Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas.
    Oncology. 2003;65(1):72-82 PMID: 12837985
  33. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system.
    Genes Dev. 1998 Jun 15;12(12):1825-36 PMID: 9637684
  34. Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its subsequent migration.
    Dev Biol. 2000 May 1;221(1):195-205 PMID: 10772801
  35. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.
    Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14608-13 PMID: 11121063
  36. The endothelin receptor-B is required for the migration of neural crest-derived melanocyte and enteric neuron precursors.
    Dev Biol. 2003 Jul 1;259(1):162-75 PMID: 12812796
  37. Nevus cells within lymph nodes. Possible metastases from a benign intradermal nevus.
    Am J Clin Pathol. 1985 Aug;84(2):220-3 PMID: 4025228
  38. Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.
    Ann Surg Oncol. 2000 May;7(4):262-7 PMID: 10819365
  39. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
    Science. 1999 Oct 15;286(5439):531-7 PMID: 10521349
  40. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
    Clin Cancer Res. 2003 Dec 15;9(17):6483-8 PMID: 14695152
  41. Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy.
    Ann Surg Oncol. 2000 Jul;7(6):456-60 PMID: 10894142
  42. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression.
    Br J Cancer. 1993 Oct;68(4):746-50 PMID: 8104462
Article Info
Journal
Nature genetics
Abbr.
Nat Genet
ISSN
1061-4036
Published
2005-10-00
Epub
2005-00-04
Pages
1047-54
Language
English
Region
United States
NLM ID
9216904
PMCID
PMC1694635
Subset
IM
Grants
NCI NIH HHS · R01 CA078461 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]